Skip to main content
Hit enter to search or ESC to close
Close Search
Origin Branding
search
Menu
  • Home
  • Services
    • Branding
  • Industries
    • Agricultural
    • Animal Health
    • Consumer
    • Industrial
    • Medical Devices
    • Pharmaceutical
    • Technology
  • Views
  • About
    • The Team
    • Why Choose Us?
  • Contact
  • +44 (0) 208 941 5811
  • search

Novartis – Cosentyx

The name Cosentyx was derived as part of a name bank creation exercise for the Novartis pipeline of future products.

Cosentyx (secukinumab) was the first FDA-approved biologic treatment of its kind. Biologic drugs are protein-based medications that are made from living sources and taken by injection or infusion.

It is used to treat moderate to severe plaque psoriasis, ankylosing spondylitis, and psoriatic arthritis in adults. Working as an immunosuppressant that reduces the effects of a chemical substance in the body that can cause inflammation.

Cosentyx is an arbitrary coinage, the word suggests comfort and strength, it sounds fast-acting and conveys ideas of regaining balance, control and improved efficacy.

  • Previous Project
  • Next Project

United Kingdom

Hampton Court

Bridge House
72 Bridge Road
East Molesey
KT8 9HF

Tel: +44 (0) 20 8941 5811

United States

Birmingham, Michigan

200 Elm Street
Birmingham
Michigan
48009

Tel: +1 248 723 7833

Our Latest Views

  • Why are vaccines important in drug development? May 4, 2022
  • Very Scary Brand Names – not created by Origin November 12, 2021
  • Change Has Happened – Questions Your Brand Team Should Be Asking May 21, 2021

© 2023 Origin Branding.

  • facebook
  • linkedin
Close Menu
  • Home
  • Services
    • Branding
  • Industries
    • Agricultural
    • Animal Health
    • Consumer
    • Industrial
    • Medical Devices
    • Pharmaceutical
    • Technology
  • Views
  • About
    • The Team
    • Why Choose Us?
  • Contact
  • +44 (0) 208 941 5811